Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Hyundai, Innocare, Mesoblast, Sarepta, Sihuan.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Ascentage, Duality, Immuneoncia, Innovent, Kura, Nasus, Otsuka, Remegen, Teva.
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Agenus, Alvotech, Bioage, Bionet, Cullinan, Dr. Reddy’s, Fortress Biotech, Genrix, Harmony, Intragrand Pharma (Suzhou), Jikang, Lupin, Kiora, Obi, PT Bio Farma, Senju, Sun Pharmaceutical, Talentec Sdn., Titan, Transpire Bio, Zydus.